LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies.

    Thran, Moritz / Pönisch, Marion / Danz, Hillary / Horscroft, Nigel / Ichtchenko, Konstantin / Tzipori, Saul / Shoemaker, Charles B

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 14632

    Abstract: The incidence of Clostridioides difficile infection (CDI) and associated mortality have increased rapidly worldwide in recent years. Therefore, it is critical to develop new therapies for CDI. Here we report on the development of mRNA-LNPs encoding ... ...

    Abstract The incidence of Clostridioides difficile infection (CDI) and associated mortality have increased rapidly worldwide in recent years. Therefore, it is critical to develop new therapies for CDI. Here we report on the development of mRNA-LNPs encoding camelid-derived V
    MeSH term(s) Swine ; Animals ; Mice ; Single-Domain Antibodies ; RNA ; Clostridioides difficile ; Half-Life ; Antibodies ; RNA, Messenger
    Chemical Substances Single-Domain Antibodies ; RNA (63231-63-0) ; Antibodies ; RNA, Messenger
    Language English
    Publishing date 2023-09-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-41092-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Conference proceedings: [No title information]

    Khanal, Rajendra / Yang, Taihua / Poenisch, Marion / Taubert, Richard / Engel, Bastian / Jaeckel, Elmar / Vogel, Arndt / Cantz, Tobias / Chevessier, Frédéric / Balakrishnan, Asha / Ott, Michael / Sharma, AmarDeep

    Zeitschrift für Gastroenterologie

    2022  Volume 60, Issue 01

    Event/congress 38. Jahrestagung der Deutsche Arbeitsgemeinschaft zum Studium der Leber, Mannheim, 2022-01-28
    Language English
    Publishing date 2022-01-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/s-0041-1740682
    Database Thieme publisher's database

    More links

    Kategorien

  3. Article ; Online: Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433].

    Yang, Taihua / Poenisch, Marion / Khanal, Rajendra / Hu, Qingluan / Dai, Zhen / Li, Ruomeng / Song, Guangqi / Yuan, Qinggong / Yao, Qunyan / Shen, Xizhong / Taubert, Richard / Engel, Bastian / Jaeckel, Elmar / Vogel, Arndt / Falk, Christine S / Schambach, Axel / Gerovska, Daniela / Araúzo-Bravo, Marcos J / Vondran, Florian W R /
    Cantz, Tobias / Horscroft, Nigel / Balakrishnan, Asha / Chevessier, Frédéric / Ott, Michael / Sharma, Amar Deep

    Journal of hepatology

    2022  Volume 77, Issue 1, Page(s) 270

    Language English
    Publishing date 2022-04-07
    Publishing country Netherlands
    Document type Published Erratum
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2022.03.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: New insights into structure and replication of the hepatitis C virus and clinical implications.

    Poenisch, Marion / Bartenschlager, Ralf

    Seminars in liver disease

    2010  Volume 30, Issue 4, Page(s) 333–347

    Abstract: With the advent of efficient systems to propagate the hepatitis C virus (HCV) in cultured cells important new discoveries have been made. For instance, several molecules required for HCV infection of hepatocytes have been identified and first insights ... ...

    Abstract With the advent of efficient systems to propagate the hepatitis C virus (HCV) in cultured cells important new discoveries have been made. For instance, several molecules required for HCV infection of hepatocytes have been identified and first insights into the entry pathway have been gained. Ribonucleic acid (RNA) replication and virion assembly were found to be tightly linked to lipid metabolism and numerous host factors contributing to viral replication have been identified. Some of them such as cyclophilin A or microRNA-122 are attractive targets for antiviral therapy as are the viral serine-type protease residing in nonstructural protein 3 (NS3) and the NS5B RNA-dependent RNA polymerase. More recently, the viral phosphoprotein NS5A emerged as an additional and very promising target for selective therapy. These results illustrate the great progress that has been made in the HCV field and how this knowledge can be used to devise innovative strategies to counteract this pathogen.
    MeSH term(s) Animals ; Cyclophilin A/physiology ; Genome, Viral/physiology ; Hepacivirus/genetics ; Hepacivirus/physiology ; Hepatitis C/genetics ; Hepatitis C/physiopathology ; Humans ; MicroRNAs/physiology ; Protein Biosynthesis/physiology ; RNA, Viral/physiology ; Viral Nonstructural Proteins/physiology ; Viral Proteins/genetics ; Viral Proteins/physiology ; Virion/physiology ; Virus Replication/physiology
    Chemical Substances MicroRNAs ; NS4B protein, flavivirus ; RNA, Viral ; Viral Nonstructural Proteins ; Viral Proteins ; Cyclophilin A (EC 5.2.1.-)
    Language English
    Publishing date 2010-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0030-1267535
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5.

    Hauser, Stefan / Poenisch, Marion / Schelling, Yvonne / Höflinger, Philip / Schuster, Stefanie / Teegler, Axel / Betten, Rabea / Gustafsson, Jan-Åke / Hübener-Schmid, Jeannette / Schlake, Thomas / Chevessier-Tünnesen, Frédéric / Horscroft, Nigel / Björkhem, Ingemar / Schöls, Ludger

    Molecular therapy. Methods & clinical development

    2019  Volume 15, Page(s) 359–370

    Abstract: Hereditary spastic paraplegia type 5 is a neurodegenerative disease caused by loss-of-function mutations in ... ...

    Abstract Hereditary spastic paraplegia type 5 is a neurodegenerative disease caused by loss-of-function mutations in the
    Language English
    Publishing date 2019-10-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2872938-9
    ISSN 2329-0501 ; 2329-0501
    ISSN (online) 2329-0501
    ISSN 2329-0501
    DOI 10.1016/j.omtm.2019.10.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications

    Poenisch, Marion / Bartenschlager, Ralf

    Seminars in Liver Disease

    2010  Volume 30, Issue 04, Page(s) 333–347

    Abstract: With the advent of efficient systems to propagate the hepatitis C virus (HCV) in cultured cells important new discoveries have been made. For instance, several molecules required for HCV infection of hepatocytes have been identified and first insights ... ...

    Abstract With the advent of efficient systems to propagate the hepatitis C virus (HCV) in cultured cells important new discoveries have been made. For instance, several molecules required for HCV infection of hepatocytes have been identified and first insights into the entry pathway have been gained. Ribonucleic acid (RNA) replication and virion assembly were found to be tightly linked to lipid metabolism and numerous host factors contributing to viral replication have been identified. Some of them such as cyclophilin A or microRNA-122 are attractive targets for antiviral therapy as are the viral serine-type protease residing in nonstructural protein 3 (NS3) and the NS5B RNA-dependent RNA polymerase. More recently, the viral phosphoprotein NS5A emerged as an additional and very promising target for selective therapy. These results illustrate the great progress that has been made in the HCV field and how this knowledge can be used to devise innovative strategies to counteract this pathogen.
    Keywords STAT-C ; NS3 protease ; NS5A protein ; NS5B RNA-dependent RNA polymerase ; miR-122 ; cyclophilin A
    Language English
    Publishing date 2010-10-19
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0030-1267535
    Database Thieme publisher's database

    More links

    Kategorien

  7. Article: Second-site mutations in Borna disease virus overexpressing viral accessory protein X.

    Poenisch, Marion / Wille, Sandra / Schneider, Urs / Staeheli, Peter

    The Journal of general virology

    2009  Volume 90, Issue Pt 8, Page(s) 1932–1936

    Abstract: The X protein of Borna disease virus (BDV) is an essential factor that regulates viral polymerase activity and inhibits apoptosis of persistently infected cells. We observed that a BDV mutant which carries an additional X gene replicated well in cell ... ...

    Abstract The X protein of Borna disease virus (BDV) is an essential factor that regulates viral polymerase activity and inhibits apoptosis of persistently infected cells. We observed that a BDV mutant which carries an additional X gene replicated well in cell culture only after acquiring second-site mutations that selectively reduced expression of the endogenous X gene. In rat brains, the virus acquired additional mutations which inactivated the ectopic X gene or altered the sequence of X. These results demonstrate that BDV readily acquires mutations if strong selection pressure is applied. They further indicate that fine-tuning of X expression determines viral fitness.
    MeSH term(s) Animals ; Borna disease virus/genetics ; Borna disease virus/physiology ; Brain/virology ; DNA Mutational Analysis ; Gene Dosage ; Gene Expression Regulation, Viral ; Gene Knockout Techniques ; Mutation, Missense ; Rats ; Sequence Analysis, DNA ; Viral Regulatory and Accessory Proteins/biosynthesis ; Viral Regulatory and Accessory Proteins/genetics ; Virus Replication
    Chemical Substances Viral Regulatory and Accessory Proteins
    Language English
    Publishing date 2009-05-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 219316-4
    ISSN 1465-2099 ; 0022-1317
    ISSN (online) 1465-2099
    ISSN 0022-1317
    DOI 10.1099/vir.0.011841-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model.

    Yang, Taihua / Poenisch, Marion / Khanal, Rajendra / Hu, Qingluan / Dai, Zhen / Li, Ruomeng / Song, Guangqi / Yuan, Qinggong / Yao, Qunyan / Shen, Xizhong / Taubert, Richard / Engel, Bastian / Jaeckel, Elmar / Vogel, Arndt / Falk, Christine S / Schambach, Axel / Gerovska, Daniela / Araúzo-Bravo, Marcos J / Vondran, Florian W R /
    Cantz, Tobias / Horscroft, Nigel / Balakrishnan, Asha / Chevessier, Frédéric / Ott, Michael / Sharma, Amar Deep

    Journal of hepatology

    2021  Volume 75, Issue 6, Page(s) 1420–1433

    Abstract: Background & aims: Therapeutic targeting of injuries that require transient restoration of proteins by mRNA delivery is an attractive approach that, until recently, has remained poorly explored. In this study, we examined the therapeutic utility of mRNA ...

    Abstract Background & aims: Therapeutic targeting of injuries that require transient restoration of proteins by mRNA delivery is an attractive approach that, until recently, has remained poorly explored. In this study, we examined the therapeutic utility of mRNA delivery for liver fibrosis and cirrhosis. Specifically, we aimed to demonstrate the therapeutic efficacy of human hepatocyte nuclear factor alpha (HNF4A) mRNA in mouse models of fibrosis and cirrhosis.
    Methods: We investigated restoration of hepatocyte functions by HNF4A mRNA transfection in vitro, and analyzed the attenuation of liver fibrosis and cirrhosis in multiple mouse models, by delivering hepatocyte-targeted biodegradable lipid nanoparticles (LNPs) encapsulating HNF4A mRNA. To identify potential mechanisms of action, we performed microarray-based gene expression profiling, single-cell RNA sequencing, and chromatin immunoprecipitation. We used primary liver cells and human liver buds for additional functional validation.
    Results: Expression of HNF4A mRNA led to restoration of the metabolic activity of fibrotic primary murine and human hepatocytes in vitro. Repeated in vivo delivery of LNP-encapsulated HNF4A mRNA induced a robust inhibition of fibrogenesis in 4 independent mouse models of hepatotoxin- and cholestasis-induced liver fibrosis. Mechanistically, we discovered that paraoxonase 1 is a direct target of HNF4A and it contributes to HNF4A-mediated attenuation of liver fibrosis via modulation of liver macrophages and hepatic stellate cells.
    Conclusion: Collectively, our findings provide the first direct preclinical evidence of the applicability of HNF4A mRNA therapeutics for the treatment of fibrosis in the liver.
    Lay summary: Liver fibrosis and cirrhosis remain unmet medical needs and contribute to high mortality worldwide. Herein, we take advantage of a promising therapeutic approach to treat liver fibrosis and cirrhosis. We demonstrate that restoration of a key gene, HNF4A, via mRNA encapsulated in lipid nanoparticles decreased injury in multiple mouse models of fibrosis and cirrhosis. Our study provides proof-of-concept that mRNA therapy is a promising strategy for reversing liver fibrosis and cirrhosis.
    MeSH term(s) Animals ; Disease Models, Animal ; Hepatocyte Nuclear Factor 4/pharmacology ; Hepatocyte Nuclear Factor 4/therapeutic use ; Liver Cirrhosis/drug therapy ; Mice ; RNA, Messenger/pharmacology ; RNA, Messenger/therapeutic use
    Chemical Substances HNF4A protein, human ; Hepatocyte Nuclear Factor 4 ; RNA, Messenger
    Language English
    Publishing date 2021-08-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2021.08.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Viral accessory protein X stimulates the assembly of functional Borna disease virus polymerase complexes.

    Poenisch, Marion / Staeheli, Peter / Schneider, Urs

    The Journal of general virology

    2008  Volume 89, Issue Pt 6, Page(s) 1442–1445

    Abstract: The Borna disease virus (BDV) proteins X and P are translated from a bicistronic viral mRNA. Here, it was shown that the rescue of recombinant BDV from cDNA was enhanced approximately eightfold if reconstitution of the viral polymerase complex was ... ...

    Abstract The Borna disease virus (BDV) proteins X and P are translated from a bicistronic viral mRNA. Here, it was shown that the rescue of recombinant BDV from cDNA was enhanced approximately eightfold if reconstitution of the viral polymerase complex was performed with an expression vector encoding X and P rather than P alone. The results provide evidence that appropriate amounts of X reduce the previously reported high sensitivity of the BDV polymerase to imbalances between the viral proteins N and P. These data indicate that X buffers an unfavourable excess of P, thereby stimulating the assembly of functional BDV polymerase complexes.
    MeSH term(s) Animals ; Borna Disease/virology ; Borna disease virus/chemistry ; Borna disease virus/physiology ; Cell Line ; DNA-Directed RNA Polymerases/metabolism ; Humans ; Nucleoproteins ; Viral Regulatory and Accessory Proteins/physiology ; Virus Replication
    Chemical Substances Nucleoproteins ; Viral Regulatory and Accessory Proteins ; DNA-Directed RNA Polymerases (EC 2.7.7.6)
    Language English
    Publishing date 2008-04-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 219316-4
    ISSN 1465-2099 ; 0022-1317
    ISSN (online) 1465-2099
    ISSN 0022-1317
    DOI 10.1099/vir.0.2008/000638-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Polymerase read-through at the first transcription termination site contributes to regulation of borna disease virus gene expression.

    Poenisch, Marion / Wille, Sandra / Staeheli, Peter / Schneider, Urs

    Journal of virology

    2008  Volume 82, Issue 19, Page(s) 9537–9545

    Abstract: An unusually long noncoding sequence is located between the N gene of Borna disease virus (BDV) and the genes for regulatory factor X and polymerase cofactor P. Most of these nucleotides are transcribed and seem to control translation of the bicistronic ... ...

    Abstract An unusually long noncoding sequence is located between the N gene of Borna disease virus (BDV) and the genes for regulatory factor X and polymerase cofactor P. Most of these nucleotides are transcribed and seem to control translation of the bicistronic X/P mRNA. We report here that Vero cells persistently infected with mutant viruses containing minor alterations in this control region showed almost normal levels of N, X, and P proteins but exhibited greatly reduced levels of mRNAs coding for these viral gene products. Surprisingly, cells infected with these BDV mutants accumulated a viral transcript 1.9 kb in length that represents a capped and polyadenylated mRNA containing the coding regions of the N, X, and P genes. Cells infected with wild-type BDV also contained substantial amounts of this read-through mRNA, which yielded both N and P protein when translated in vitro. Viruses carrying mutations that promoted read-through transcription at the first gene junction failed to replicate in the brain of adult rats. In the brains of newborn rats, these mutant viruses were able to replicate after acquiring second-site mutations in or near the termination signal located downstream of the N gene. Thus, sequence elements adjacent to the core termination signal seem to regulate the frequency by which the polymerase terminates transcription after the N gene. We conclude from these observations that BDV uses read-through transcription for fine-tuning the expression of the N, X, and P genes which, in turn, influence viral polymerase activity.
    MeSH term(s) Animals ; Base Sequence ; Borna disease virus/genetics ; Borna disease virus/metabolism ; Brain/metabolism ; Chlorocebus aethiops ; Gene Expression Regulation, Viral ; Models, Genetic ; Molecular Sequence Data ; Mutation ; Polyadenylation ; RNA, Messenger/metabolism ; Rats ; Transcription, Genetic ; Vero Cells ; Virus Replication
    Chemical Substances RNA, Messenger
    Language English
    Publishing date 2008-07-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.00639-08
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top